Literature DB >> 2050599

The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity.

B S Charak1, R Louie, B Malloy, P Twomey, A Mazumder.   

Abstract

The effects of certain antibiotics on the colony forming activity of human bone marrow cells in semisolid methylcellulose medium in vitro and on murine BM cells in spleen colony forming units (cfu-s) in vivo were evaluated. Amikacin, gentamicin, piperacillin, co-trimoxazole and pentamidine had little or no effect on human bone marrow progenitor cell function; amphotericin B, aztreonam, ceftazidime and imipenem caused significant suppression of human colony forming unit-erythroid (cfu-e), burst forming unit-erythroid (bfu-e) and colony forming unit-granulocyte macrophage (cfu-gm) at both peak and trough serum concentrations. At molar equivalent concentrations ceftazidime, cefotaxime and cefoperazone caused significant decreases in human cfu-e, bfu-e and cfu-gm in vitro (P less than 0.01) and murine cfu-s in vivo (P less than 0.05); cefoxitin, cefuroxime, ceftizoxime and ceftriaxone did not suppress human bone marrow progenitor cell activity. Gentamicin, piperacillin and ceftriaxone had no effect on murine cfu-s formation. Further studies to evaluate the effect of these antibiotics on human bone marrow in vivo are suggested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050599     DOI: 10.1093/jac/27.1.95

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans.

Authors:  Cynthia L Bristow; Ronald Winston
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

Review 2.  An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in?

Authors:  Robert C Owens
Journal:  Crit Care       Date:  2008-05-21       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.